S14 Ep13: Dissecting Clinical Trial and Real-World Data for ADCs in TNBC
OncLive® On Air - Un pódcast de OncLive® On Air
In this podcast, experts Filipa Lynce, MD, and Rita Nanda, MD, discuss recent clinical trial and real-world data for antibody-drug conjugates (ADCs) used to treat triple-negative breast cancer (TNBC).
